Monocytes prevent apoptosis of iPSCs and promote differentiation of kidney organoids

Ekaterina Pecksen,Sergey Tkachuk,Cristoph Schröder,Marc Vives Enrich,Anindita Neog,Cory P. Johnson,Niko Lachmann,Hermann Haller,Yulia Kiyan
DOI: https://doi.org/10.1186/s13287-024-03739-8
2024-05-05
Stem Cell Research & Therapy
Abstract:Induced pluripotent stem cells (iPSCs)-derived kidney organoids are a promising model for studying disease mechanisms and renal development. Despite several protocols having been developed, further improvements are needed to overcome existing limitations and enable a wider application of this model. One of the approaches to improve the differentiation of renal organoids in vitro is to include in the system cell types important for kidney organogenesis in vivo, such as macrophages. Another approach could be to improve cell survival. Mesodermal lineage differentiation is the common initial step of the reported protocols. The glycogen synthase kinase-3 (GSK-3) activity inhibitor, CHIR99021 (CHIR), is applied to induce mesodermal differentiation. It has been reported that CHIR simultaneously induces iPSCs apoptosis that can compromise cell differentiation. We thought to interfere with CHIR-induced apoptosis of iPSCs using rapamycin.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?